NEW WAVE HOLDINGS LTD. (5FX)
Annual General Meeting :
Annual General Meeting :
Lucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 13, 2026
Perrigo Announces Quarterly Dividend
Johnson & Johnson - Johnson & Johnsons RYBREVANTFASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Priority Review as potential first-in-class EGFR- and MET-targeted subcutaneous treatment for advanced head and neck cancer
Phunware Announces Key Appointments Following Successful HITEC Industry Conference; Expansion of AI Concierge Footprint
20/20 BioLabs to Host Investor Webinar on August 5, 2026, to Discuss Commercial Opportunities Following Management’s Recent East Asia Business Development Tour
Veru to Participate in Fireside Chat at the Canaccord Genuitys 46th Annual Growth Investors Conference
SAB BIO to Host Second Quarter 2026 Financial Results Conference Call and Webcast on August 6, 2026, 08:30 AM ET
IperionX – June 2026 Quarterly Report
Cingulate Announces Publication of Phase 3 ADHD Trial Results in Journal of Child and Adolescent Psychopharmacology